Bristol hep C drug helps cure 97 pct of HIV coinfected patients-study
February 26, 2015 at 15:15 PM EST
Feb 26 (Reuters) - Ninety-seven percent of hepatitis C patients also infected with HIV were cured of the liver-destroying virus after 12 weeks of treatment with Bristol-Myers Squibb's daclatasvir and Gilead Sciences' Sovaldi, according to data from a study presented on Thursday.
